Mitsubishi UFJ Trust & Banking Corp Raises Stock Holdings in DaVita Inc. (NYSE:DVA)

Mitsubishi UFJ Trust & Banking Corp increased its stake in shares of DaVita Inc. (NYSE:DVA) by 15.3% in the fourth quarter, HoldingsChannel reports. The firm owned 128,528 shares of the company’s stock after buying an additional 17,008 shares during the quarter. Mitsubishi UFJ Trust & Banking Corp’s holdings in DaVita were worth $19,221,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. MML Investors Services LLC boosted its stake in shares of DaVita by 1.3% during the 3rd quarter. MML Investors Services LLC now owns 5,300 shares of the company’s stock worth $869,000 after purchasing an additional 68 shares during the last quarter. Exchange Traded Concepts LLC boosted its position in DaVita by 8.3% during the fourth quarter. Exchange Traded Concepts LLC now owns 891 shares of the company’s stock worth $133,000 after acquiring an additional 68 shares during the last quarter. Impact Partnership Wealth LLC raised its holdings in DaVita by 3.7% in the 4th quarter. Impact Partnership Wealth LLC now owns 1,941 shares of the company’s stock valued at $290,000 after acquiring an additional 70 shares during the last quarter. Contravisory Investment Management Inc. lifted its stake in shares of DaVita by 1.2% during the 4th quarter. Contravisory Investment Management Inc. now owns 6,082 shares of the company’s stock worth $910,000 after purchasing an additional 73 shares during the period. Finally, Nilsine Partners LLC boosted its holdings in shares of DaVita by 0.8% during the fourth quarter. Nilsine Partners LLC now owns 11,160 shares of the company’s stock worth $1,669,000 after purchasing an additional 92 shares during the last quarter. Institutional investors and hedge funds own 90.12% of the company’s stock.

DaVita Trading Up 0.9 %

NYSE DVA opened at $152.73 on Friday. The firm has a market capitalization of $12.22 billion, a price-to-earnings ratio of 14.22, a PEG ratio of 1.07 and a beta of 0.99. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. DaVita Inc. has a one year low of $125.64 and a one year high of $179.60. The company’s 50 day moving average price is $157.71 and its 200 day moving average price is $157.50.

DaVita (NYSE:DVA) last issued its earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. On average, sell-side analysts predict that DaVita Inc. will post 10.76 EPS for the current year.

Analyst Upgrades and Downgrades

DVA has been the subject of several analyst reports. Sanford C. Bernstein set a $184.00 target price on DaVita in a research note on Friday, February 21st. Cowen reiterated a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. StockNews.com downgraded shares of DaVita from a “buy” rating to a “hold” rating in a report on Friday, March 21st. Finally, Barclays increased their price target on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.